Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;111:1242-1249
doi: 10.1161/01.CIR.0000157697.54255.CE
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sutton-Tyrrell, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sutton-Tyrrell, K.
Related Collections
Right arrow Risk Factors
Right arrow Epidemiology

(Circulation. 2005;111:1242-1249.)
© 2005 American Heart Association, Inc.


Epidemiology

Sex Hormone–Binding Globulin and the Free Androgen Index Are Related to Cardiovascular Risk Factors in Multiethnic Premenopausal and Perimenopausal Women Enrolled in the Study of Women Across the Nation (SWAN)

Kim Sutton-Tyrrell, DrPH; Rachel P. Wildman, PhD; Karen A. Matthews, PhD; Claudia Chae, MD, MPH; Bill L. Lasley, PhD; Sarah Brockwell, PhD; Richard C. Pasternak, MD; Donald Lloyd-Jones, MD, ScM; Mary Fran Sowers, PhD; Javier I. Torréns, MD, for the SWAN Investigators

From the Department of Epidemiology (K.S.-T., S.B.), Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pa; Department of Epidemiology (R.P.W.), Tulane University School of Public Health and Tropical Medicine, New Orleans, La; Department of Psychiatry (K.A.M.), University of Pittsburgh School of Medicine, Pittsburgh, Pa; Cardiology Division (C.C., R.C.P.), Massachusetts General Hospital, and Division of Preventive Medicine, Brigham and Women’s Hospital, Boston, Mass; Department of Population Health and Reproduction (B.L.L.), University of California—Davis, Davis, Calif; Feinberg School of Medicine (D.L.-J.), Northwestern University, Chicago, Ill; Department of Epidemiology (M.F.S.), School of Public Health, University of Michigan, Ann Arbor, Mich; and Department of Obstetrics, Gynecology and Women’s Health (J.L.T.), New Jersey Medical School, Newark, NJ.

Correspondence to Kim Sutton-Tyrrell, Department of Epidemiology, University of Pittsburgh, 127 Parran Hall/130 DeSoto St, Pittsburgh, PA 15261. E-mail Tyrrell{at}edc.pitt.edu

Received September 17, 2004; revision received December 17, 2004; accepted December 28, 2004.

Background— Recent clinical trials have shifted attention away from estrogens and toward androgens and sex hormone–binding globulin (SHBG) as potential mediators of increasing cardiovascular (CV) risk in women at midlife.

Methods and Results— The correlation between reproductive hormones and CV risk factors was evaluated in a multiethnic (white, black, Hispanic, Chinese, and Japanese) sample of 3297 premenopausal and perimenopausal women. Testosterone and estradiol (E2) were evaluated along with SHBG and the free androgen index (FAI), the amount of testosterone not bound by SHBG. Low SHBG and high FAI were strongly and consistently related to elevated CV risk factors (higher insulin, glucose, and hemostatic and inflammatory markers and adverse lipids) even after controlling for body mass index (P<0.001 for all). Low levels of E2 were associated with elevated CV risk factors to a lesser degree. These observations were consistent across the 5 ethnic groups. Compared with whites, blacks had higher levels of SHBG and lower levels of FAI, and Chinese had lower levels of SHBG and higher levels of FAI.

Conclusions— Low SHBG and high FAI are strongly associated with CV risk factors in racially diverse women, and thus, androgens likely play a role in the CV risk profile of perimenopausal women.


Key Words: hormones • aging • sex • menopause • risk factors




This article has been cited by other articles:


Home page
Arch Intern MedHome page
M. R. Sowers, J. Randolph Jr, M. Jannausch, B. Lasley, E. Jackson, and D. McConnell
Levels of Sex Steroid and Cardiovascular Disease Measures in Premenopausal and Hormone-Treated Women at Midlife: Implications for the "Timing Hypothesis"
Arch Intern Med, October 27, 2008; 168(19): 2146 - 2153.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. C. Thurston, K. Sutton-Tyrrell, S. A. Everson-Rose, R. Hess, and K. A. Matthews
Hot Flashes and Subclinical Cardiovascular Disease: Findings From the Study of Women's Health Across the Nation Heart Study
Circulation, September 16, 2008; 118(12): 1234 - 1240.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
I. Janssen, L. H. Powell, S. Crawford, B. Lasley, and K. Sutton-Tyrrell
Menopause and the Metabolic Syndrome: The Study of Women's Health Across the Nation
Arch Intern Med, July 28, 2008; 168(14): 1568 - 1575.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
V. M. Miller and S. P. Duckles
Vascular Actions of Estrogens: Functional Implications
Pharmacol. Rev., June 1, 2008; 60(2): 210 - 241.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Santoro, S. L. Crawford, W. L. Lasley, J. L. Luborsky, K. A. Matthews, D. McConnell, J. F. Randolph Jr., E. B. Gold, G. A. Greendale, S. G. Korenman, et al.
Factors Related to Declining Luteal Function in Women during the Menopausal Transition
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1711 - 1721.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. R. Davis, S. M. Shah, D. P. McKenzie, J. Kulkarni, S. L. Davison, and R. J. Bell
Dehydroepiandrosterone Sulfate Levels Are Associated with More Favorable Cognitive Function in Women
J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 801 - 808.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
P. Roy, M. Alevizaki, and I. Huhtaniemi
In vitro bioassays for androgens and their diagnostic applications
Hum. Reprod. Update, January 1, 2008; 14(1): 73 - 82.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
D. P. Rose, S. M. Haffner, and J. Baillargeon
Adiposity, the Metabolic Syndrome, and Breast Cancer in African-American and White American Women
Endocr. Rev., December 1, 2007; 28(7): 763 - 777.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. B. Spencer, M. Klein, A. Kumar, and R. Azziz
The Age-Associated Decline of Androgens in Reproductive Age and Menopausal Black and White Women
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4730 - 4733.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
O. Celik, I. Sahin, N. Celik, S. Hascalik, L. Keskin, H. Ozcan, A. Uckan, and F. Kosar
Diagnostic potential of serum N-terminal pro-B-type brain natriuretic peptide level in detection of cardiac wall stress in women with polycystic ovary syndrome: a cross-sectional comparison study
Hum. Reprod., November 1, 2007; 22(11): 2992 - 2998.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. H. Wu, M. C. Yu, C.-C. Tseng, F. Z. Stanczyk, and M. C. Pike
Diabetes and risk of breast cancer in Asian-American women
Carcinogenesis, July 1, 2007; 28(7): 1561 - 1566.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. H. Golden, A. S. Dobs, D. Vaidya, M. Szklo, S. Gapstur, P. Kopp, K. Liu, and P. Ouyang
Endogenous Sex Hormones and Glucose Tolerance Status in Postmenopausal Women
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1289 - 1295.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Y. Chang, S. M. Abdullah, T. Jain, H. G. Stanek, S. R. Das, D. K. McGuire, R. J. Auchus, and J. A. de Lemos
Associations Among Androgens, Estrogens, and Natriuretic Peptides in Young Women: Observations From the Dallas Heart Study
J. Am. Coll. Cardiol., November 7, 2006; (2006) j.jacc.2006.10.040v1.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Chen, M. R. Sowers, F. M. Moran, D. S. McConnell, N. A. Gee, G. A. Greendale, C. Whitehead, S. E. Kasim-Karakas, and B. L. Lasley
Circulating Bioactive Androgens in Midlife Women
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4387 - 4394.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. Hsia, J. E. Manson, K. C. Johnson, S. L. Hendrix, S. R. Heckbert, S. Crawford, C. B. Eaton, and J. B. Kostis
Estrogen and Heart Disease: Alternatives to a Paradigm in Crisis--Reply
Arch Intern Med, October 23, 2006; 166(19): 2160 - 2160.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. E. Wierman, R. Basson, S. R. Davis, S. Khosla, K. K. Miller, W. Rosner, and N. Santoro
Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3697 - 3710.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.-J. Chen, W.-S. Yang, J.-H. Yang, C. K. Hsiao, Y.-S. Yang, and H.-N. Ho
Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS
Hum. Reprod., September 1, 2006; 21(9): 2266 - 2271.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Codner, N. Soto, P. Lopez, L. Trejo, A. Avila, F. C. Eyzaguirre, G. Iniguez, and F. Cassorla
Diagnostic Criteria for Polycystic Ovary Syndrome and Ovarian Morphology in Women with Type 1 Diabetes Mellitus
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2250 - 2256.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. A. Matthews, N. Santoro, B. Lasley, Y. Chang, S. Crawford, R. C. Pasternak, K. Sutton-Tyrrell, and M. Sowers
Relation of Cardiovascular Risk Factors in Women Approaching Menopause to Menstrual Cycle Characteristics and Reproductive Hormones in the Follicular and Luteal Phases
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1789 - 1795.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
W.-H. Wu, Y.-P. Kang, N.-H. Wang, H.-J. Jou, and T.-A. Wang
Sesame Ingestion Affects Sex Hormones, Antioxidant Status, and Blood Lipids in Postmenopausal Women
J. Nutr., May 1, 2006; 136(5): 1270 - 1275.
[Abstract] [Full Text] [PDF]